Recent developments with Rockwell Medical Inc (RMTI) have led to the company’s beta value being reach 1.42 cents.

Rockwell Medical Inc (NASDAQ: RMTI) kicked off on Monday, up 18.46% from the previous trading day, before settling in for the closing price of $2.98. Over the past 52 weeks, RMTI has traded in a range of $1.16-$3.43.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 6.03% over the past five years. While this was happening, its average annual earnings per share was recorded 91.67%. With a float of $27.35 million, this company’s outstanding shares have now reached $29.13 million.

Let’s look at the performance matrix of the company that is accounted for 237 employees. In terms of profitability, gross margin is 13.44%, operating margin of -3.28%, and the pretax margin is -5.06%.

Rockwell Medical Inc (RMTI) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Rockwell Medical Inc is 11.86%, while institutional ownership is 20.22%.

Rockwell Medical Inc (RMTI) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 91.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.00% during the next five years compared to 44.20% growth over the previous five years of trading.

Rockwell Medical Inc (NASDAQ: RMTI) Trading Performance Indicators

Take a look at Rockwell Medical Inc’s (RMTI) current performance indicators. Last quarter, stock had a quick ratio of 1.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.16.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.17, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.07 in one year’s time.

Technical Analysis of Rockwell Medical Inc (RMTI)

Rockwell Medical Inc (NASDAQ: RMTI) saw its 5-day average volume 0.81 million, a positive change from its year-to-date volume of 0.24 million. As of the previous 9 days, the stock’s Stochastic %D was 54.46%. Additionally, its Average True Range was 0.25.

During the past 100 days, Rockwell Medical Inc’s (RMTI) raw stochastic average was set at 97.24%, which indicates a significant increase from 92.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 95.27% in the past 14 days, which was higher than the 65.43% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.30, while its 200-day Moving Average is $1.79. Nevertheless, the first resistance level for the watch stands at $3.73 in the near term. At $3.93, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.27. If the price goes on to break the first support level at $3.19, it is likely to go to the next support level at $2.85. The third support level lies at $2.65 if the price breaches the second support level.

Rockwell Medical Inc (NASDAQ: RMTI) Key Stats

The company with the Market Capitalisation of 109.54 million has total of 30,316K Shares Outstanding. Its annual sales at the moment are 83,610 K in contrast with the sum of -8,440 K annual income. Company’s last quarter sales were recorded 25,830 K and last quarter income was 340 K.